| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |